The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
about
Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell LymphomaNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewIntegrative systems medicine approaches to identify molecular targets in lymphoid malignanciesThe IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesisAID-induced remodeling of immunoglobulin genes and B cell fate.Combination of cellular population data and CytoDiff analyses for the diagnosis of lymphocytosis.MicroRNA and gene networks in human diffuse large B-cell lymphomaThe class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model.Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.B-cell receptor signaling in diffuse large B-cell lymphoma.Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium PrClinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma.VH1-44 gene usage defines a subset of canine B-cell lymphomas associated with better patient survival.The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age.Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.The significance of serum immunoglobulin paraprotein in diffuse large B-cell lymphoma.The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma.Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification.Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma.Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma.
P2860
Q26853170-2BD09F15-D70C-465B-A461-C7E683805E0EQ27304386-B7B195CD-5F97-4B8F-984B-A83205FFAEF6Q28067817-6D4FAA73-5BE2-44F6-91EA-1AE1BCC4FA22Q28075599-0CD2E446-4D6B-4140-9753-E4506802EE9DQ33576896-DB447816-2A70-45FD-9F6B-6EB1A8D20FA4Q34004920-FACC4D3C-00C4-44D8-A870-E9C9F152A9A4Q34293107-939C803C-C4B8-4BE1-9E29-8BDD30D9FD8AQ34619195-010AD46F-7231-48CF-8F12-DF9ACD519217Q35063947-E23B40D0-5FC4-461C-ABCB-68B78B560FF9Q35218042-C0734290-FE69-48B9-BB91-1FF6213480CBQ36268482-3AF5FE13-7D40-408D-9FE1-13B509949B64Q36563205-3E834E38-0A93-4E6F-A408-764E7F607581Q37006876-EE1F8012-8DE3-4B81-B73F-8308DE857BA9Q37685724-07F75424-6E13-41E6-B728-373BB624FCF2Q38831146-9BB4542E-C963-48E0-9A6D-4A05BD19717CQ41952665-A783FEF4-59B4-40B0-A807-3C807CA69ABEQ43004464-95E7E8B8-13EC-4D1A-9A3D-3092C2D80697Q43084995-922DFAA4-6AA2-4B8A-B0A1-36C98E0A6D00Q43778801-85B3CC1B-E03F-4BAC-9EBB-549F892FED1CQ48195072-57224AF1-29F3-4678-A2E9-BFE9FE3828A6Q50953796-0642BEB1-034D-4307-ADEC-F2E2B59CAF8FQ51075846-B3FE1901-4A24-47EB-B08B-743943A3FB0BQ51767473-471F10EB-AB03-4140-9A05-BDA15DDBE689Q53117498-4F211A64-6DD7-4613-A4A7-81A88C1338FAQ53210229-204D94E5-B3AB-43CD-96FF-0F50E9B5361B
P2860
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma.
@en
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma.
@nl
type
label
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma.
@en
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma.
@nl
prefLabel
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma.
@en
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
The isotype of the BCR as a su ...... diffuse large B-cell lymphoma
@en
P2093
B Lenormand
F Parmentier
J-M Picquenot
P Bertrand
P2860
P2888
P304
P356
10.1038/LEU.2010.302
P577
2011-01-14T00:00:00Z